Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4INDIVIOR

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 9687454

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22410

Patent Use Code : U-1464

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID DE...

Patent Expiration Date : 2029-08-07

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 9687454

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22410

Patent Use Code : U-1464

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID DE...

Patent Expiration Date : 2029-08-07

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 9687454

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22410

Patent Use Code : U-1464

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID DE...

Patent Expiration Date : 2029-08-07

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

US Patent Number : 9687454

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22410

Patent Use Code : U-1464

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID DE...

Patent Expiration Date : 2029-08-07

blank